Molecular biologic substaging of stage I lung cancer according to gender and histology
- 1 March 2000
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 69 (3) , 882-886
- https://doi.org/10.1016/s0003-4975(99)01522-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markersThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.Journal of Clinical Oncology, 1998
- Women and Lung CancerChest, 1997
- Immunocytochemical markers in stage I lung cancer: relevance to prognosis.Journal of Clinical Oncology, 1997
- Revisions in the International System for Staging Lung CancerChest, 1997
- Angiogenesis and molecular biologic substaging in patients with stage I non—small cell lung cancerThe Annals of Thoracic Surgery, 1996
- Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrenceCancer, 1995
- Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung.Journal of Clinical Oncology, 1995
- Lung cancer in women. Lahey clinic experience, 1957–1980Cancer, 1985